Dermata Therapeutics (NASDAQ: DRMA) director gets 2,500 options granted

Rhea-AI Filing Summary

Dermata Therapeutics director Brittany Bradrick reported a new equity award. On January 2, 2026, she was granted a stock option to buy 2,500 shares of common stock at $2.18 per share. The option was received at no cost and is held directly. Following this grant, she beneficially owns 2,500 derivative securities in the form of this option.

According to the vesting terms, the 2,500 underlying shares vest in twelve substantially equal monthly installments. The first installment vests on the one‑month anniversary of the grant date, with additional installments vesting monthly thereafter, as long as she continues in service through each vesting date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bradrick Brittany

(Last) (First) (Middle)

3525 DEL MAR HEIGHTS RD.,

#322

(Street)

SAN DIEGO CA 92130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dermata Therapeutics, Inc. [ DRMA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.18	01/02/2026		A		2,500		(1)	01/01/2036	Common Stock	2,500	$0	2,500	D

Explanation of Responses:

1. The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date.

	/s/ Gerald T. Proehl, Attorney-in-Fact	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Dermata Therapeutics (DRMA) report on this Form 4?

The Form 4 reports that director Brittany Bradrick received a stock option (right to buy) covering 2,500 shares of common stock at $2.18 per share on January 2, 2026.

How many Dermata Therapeutics (DRMA) shares are covered by the new stock option?

The new stock option granted to Brittany Bradrick covers 2,500 shares of Dermata Therapeutics, Inc. common stock.

What is the exercise price and vesting schedule of the DRMA stock option granted to Brittany Bradrick?

The stock option has an exercise price of $2.18 per share. The 2,500 underlying shares vest in twelve substantially equal monthly installments, starting on the one‑month anniversary of the grant date and continuing monthly, subject to her continuous service.

Is the new DRMA stock option held directly or indirectly by the reporting person?

The Form 4 indicates the 2,500 stock options are held directly (coded "D") by Brittany Bradrick, with no nature of indirect beneficial ownership listed.

How many derivative securities does Brittany Bradrick own after this Dermata Therapeutics transaction?

After this grant, Brittany Bradrick beneficially owns 2,500 derivative securities, all represented by this stock option to acquire common stock.

Does the vesting of Brittany Bradrick’s DRMA stock option depend on continued service?

Yes. The footnote states that each monthly installment of the 2,500 underlying shares vests only if the reporting person continues in service through the applicable vesting date.